STAA
Price
$16.91
Change
+$0.30 (+1.81%)
Updated
Jul 8, 04:59 PM (EDT)
Capitalization
1.91B
29 days until earnings call
XRAY
Price
$16.53
Change
+$0.59 (+3.70%)
Updated
Jul 8 closing price
Capitalization
6.69B
22 days until earnings call
Interact to see
Advertisement

STAA vs XRAY

Header iconSTAA vs XRAY Comparison
Open Charts STAA vs XRAYBanner chart's image
STAAR Surgical
Price$16.91
Change+$0.30 (+1.81%)
Volume$11.13K
Capitalization1.91B
DENTSPLY SIRONA
Price$16.53
Change+$0.59 (+3.70%)
Volume$2.39M
Capitalization6.69B
STAA vs XRAY Comparison Chart in %
Loading...
STAA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XRAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
STAA vs. XRAY commentary
Jul 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is STAA is a Buy and XRAY is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 09, 2025
Stock price -- (STAA: $16.91 vs. XRAY: $16.53)
Brand notoriety: STAA and XRAY are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: STAA: 58% vs. XRAY: 88%
Market capitalization -- STAA: $1.91B vs. XRAY: $6.69B
STAA [@Medical Specialties] is valued at $1.91B. XRAY’s [@Medical Specialties] market capitalization is $6.69B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.58B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

STAA’s FA Score shows that 0 FA rating(s) are green whileXRAY’s FA Score has 1 green FA rating(s).

  • STAA’s FA Score: 0 green, 5 red.
  • XRAY’s FA Score: 1 green, 4 red.
According to our system of comparison, XRAY is a better buy in the long-term than STAA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

STAA’s TA Score shows that 3 TA indicator(s) are bullish while XRAY’s TA Score has 3 bullish TA indicator(s).

  • STAA’s TA Score: 3 bullish, 6 bearish.
  • XRAY’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, XRAY is a better buy in the short-term than STAA.

Price Growth

STAA (@Medical Specialties) experienced а -0.65% price change this week, while XRAY (@Medical Specialties) price change was -0.06% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.52%. For the same industry, the average monthly price growth was +0.66%, and the average quarterly price growth was -0.00%.

Reported Earning Dates

STAA is expected to report earnings on Oct 29, 2025.

XRAY is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Medical Specialties (+1.52% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XRAY($6.69B) has a higher market cap than STAA($1.91B). STAA has higher P/E ratio than XRAY: STAA (90.79) vs XRAY (19.23). XRAY YTD gains are higher at: -11.119 vs. STAA (-31.618). XRAY has higher annual earnings (EBITDA): 249M vs. STAA (33.2M). XRAY has more cash in the bank: 334M vs. STAA (221M). STAA has less debt than XRAY: STAA (35.8M) vs XRAY (2.3B). XRAY has higher revenues than STAA: XRAY (3.97B) vs STAA (322M).
STAAXRAYSTAA / XRAY
Capitalization1.91B6.69B29%
EBITDA33.2M249M13%
Gain YTD-31.618-11.119284%
P/E Ratio90.7919.23472%
Revenue322M3.97B8%
Total Cash221M334M66%
Total Debt35.8M2.3B2%
FUNDAMENTALS RATINGS
STAA vs XRAY: Fundamental Ratings
STAA
XRAY
OUTLOOK RATING
1..100
1018
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
3
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9496
PRICE GROWTH RATING
1..100
6357
P/E GROWTH RATING
1..100
9189
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

XRAY's Valuation (3) in the Medical Specialties industry is significantly better than the same rating for STAA (83). This means that XRAY’s stock grew significantly faster than STAA’s over the last 12 months.

XRAY's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as STAA (100). This means that XRAY’s stock grew similarly to STAA’s over the last 12 months.

STAA's SMR Rating (94) in the Medical Specialties industry is in the same range as XRAY (96). This means that STAA’s stock grew similarly to XRAY’s over the last 12 months.

XRAY's Price Growth Rating (57) in the Medical Specialties industry is in the same range as STAA (63). This means that XRAY’s stock grew similarly to STAA’s over the last 12 months.

XRAY's P/E Growth Rating (89) in the Medical Specialties industry is in the same range as STAA (91). This means that XRAY’s stock grew similarly to STAA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
STAAXRAY
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
68%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 1 day ago
71%
Momentum
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 1 day ago
56%
MACD
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 1 day ago
55%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 1 day ago
61%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 1 day ago
63%
Advances
ODDS (%)
Bullish Trend 6 days ago
74%
Bullish Trend 6 days ago
58%
Declines
ODDS (%)
Bearish Trend 22 days ago
86%
Bearish Trend 26 days ago
70%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 1 day ago
78%
Aroon
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 1 day ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
STAA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XRAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MFVSX17.62N/A
N/A
MassMutual Equity Opports R5
EMGNX30.65N/A
N/A
Allspring Emerging Markets Equity Inst
DIEYX43.77N/A
N/A
BNY Mellon International Core Equity Y
EPLIX22.21-0.01
-0.05%
NYLI Epoch U.S. Equity Yield Inv Class
AMPCX34.69-0.02
-0.06%
American Funds AMCAP C

STAA and

Correlation & Price change

A.I.dvisor indicates that over the last year, STAA has been loosely correlated with XRAY. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if STAA jumps, then XRAY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STAA
1D Price
Change %
STAA100%
-7.00%
XRAY - STAA
53%
Loosely correlated
-4.38%
WST - STAA
44%
Loosely correlated
-0.35%
RVTY - STAA
41%
Loosely correlated
-2.57%
A - STAA
41%
Loosely correlated
-1.75%
MTD - STAA
40%
Loosely correlated
-1.70%
More